This study explored attitudes towards exercise, recollections of physical activity advice received, and the dimensions that influence physical activity (PA) engagement in individuals diagnosed with pulmonary hypertension. Virtual semi-structured interviews (n = 21) were conducted with those diagnosed with pulmonary hypertension. 

Group discussion session at Genetics-inspired Therapeutics for PH

Presented at Genetics-inspired Therapeutics for PH by Chris Rhodes, Imperial College London

Presented at Genetics-inspired Therapeutics for PH by Rachel Gurrell, Apollo Therapeutics

Presented at Genetics-inspired Therapeutics for PH by Patrick Andre, Diagonal Therapeutics

Presented at Genetics-inspired Therapeutics for PH by Alex Rothman, The University of Sheffield and Ana-Maria Tanase, Novartis

Presented at Genetics-inspired Therapeutics for PH by Kevin Hart, Pfizer

Presented at Genetics-inspired Therapeutics for PH by Khodr Tello, Justus-Liebig-Universität Gießen

The SPHInX study is the first-ever randomized controlled trial (RCT) seeking to inform an area of equipoise regarding the efficacy of oral anticoagulation as adjunct therapy in systemic sclerosis-related pulmonary arterial hypertension (SSc-PAH).

Presented at Genetics-inspired Therapeutics for PH by Ardeschir Ghofrani, Justus-Liebig-Universität Gießen